Fig. 6From: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort studyThe dynamics of biochemical or haematological parameters. No significant change was observed in terms of WBC counts a, PLT counts b, transaminase c, Creatinine d, Glucose e and blood lipid levels f during follow-up periodBack to article page